NCT05698212View on ClinicalTrials.gov

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

PHASE2UnknownINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

March 25, 2023

Study Completion Date

April 10, 2023

Conditions
EndometriosisDiagnosis
Interventions
DIAGNOSTIC_TEST

MetriDx

Biopsied tissue will be analyze by proprietary LDT, MetriDx, and compared to laparoscopy diagnostic report on record

Trial Locations (3)

48602

NOT_YET_RECRUITING

Valley OB-GYN Clinic, PC, Saginaw

77024

RECRUITING

University of Texas Physician's Women's Center--Memorial City, Houston

78412

RECRUITING

Corpus Christi Women's Center, Corpus Christi

Sponsors

Lead Sponsor

Hera Biotech, Inc.
All Listed Sponsors
lead

Hera Biotech, Inc.

INDUSTRY